Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-06-20
DOI
10.3389/fonc.2016.00145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo
- (2015) Wei Fan et al. JOURNAL OF DRUG TARGETING
- Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells
- (2015) Petra Gener et al. Nanomedicine-Nanotechnology Biology and Medicine
- Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
- (2015) Van T. M. Nguyen et al. Nature Communications
- Selective killing of breast cancer cells expressing activated CD44 using CD44 ligand-coated nanoparticles in vitro and in vivo
- (2015) Cuixia Yang et al. Oncotarget
- Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
- (2015) Xintao Li et al. Scientific Reports
- Expression and Interactions Between Cell Adhesion Molecules CD44v6 and E-Cadherin in Human Gliomas
- (2015) Julia Bar et al. Advances in Clinical and Experimental Medicine
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- CD44 acts through RhoA to regulate YAP signaling
- (2014) Yuchen Zhang et al. CELLULAR SIGNALLING
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis
- (2014) Hao Jiang et al. TUMOR BIOLOGY
- Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
- (2014) J Diessner et al. Cell Death & Disease
- Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6
- (2014) FAHE JI et al. Oncology Letters
- Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles
- (2013) Chenchen Qian et al. BIOMATERIALS
- Correlation of CD44v6 expression with ovarian cancer progression and recurrence
- (2013) Jun Shi et al. BMC CANCER
- Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression
- (2013) Balázs Bánky et al. Molecular Cancer
- CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
- (2013) SEIYA SAITO et al. ONCOLOGY REPORTS
- Immunophenotyping invasive breast cancer: paving the road for molecular imaging
- (2012) Jeroen F Vermeulen et al. BMC CANCER
- Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan
- (2012) Stephen Hiscox et al. BMC CANCER
- Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma
- (2012) Zheng-Jun Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion
- (2012) Hyeong Kim INTERNATIONAL JOURNAL OF ONCOLOGY
- Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
- (2012) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells
- (2012) Maitham A. Khajah et al. PLoS One
- CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
- (2011) Eleonor Olsson et al. BMC CANCER
- HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
- (2011) Wei Bao et al. GASTROENTEROLOGY
- CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance
- (2011) Thorsten Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- With maturity comes confidence: EBCTCG tamoxifen update
- (2011) Stephen K Chia et al. LANCET
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
- (2011) Christopher A. Maxwell et al. PLOS BIOLOGY
- Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
- (2010) J Hao et al. BRITISH JOURNAL OF CANCER
- Clinical significance of pAKT and CD44v6 overexpression with breast cancer
- (2010) Pei Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Delivery of CD44 shRNA/Nanoparticles within Cancer Cells
- (2009) Suniti Misra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44
- (2008) Zsuzsanna Pályi-Krekk et al. CANCER LETTERS
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- CD44-Epidermal Growth Factor Receptor Interaction Mediates Hyaluronic Acid-promoted Cell Motility by Activating Protein Kinase C Signaling Involving Akt, Rac1, Phox, Reactive Oxygen Species, Focal Adhesion Kinase, and MMP-2
- (2008) Youngmi Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
- (2008) JMW Gee et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now